Staar Surgical Co: Form 10-Q for the period ended Mar 29, 2024
Filed with the SEC on May 7, 2024 and accepted by EDGAR at May 7, 2024, 16:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-30 to 2024-03-29 | $77.4m | us-gaap:Revenues |
| Cost of revenue | 3 months2023-12-30 to 2024-03-29 | $16.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-12-30 to 2024-03-29 | $61.0m | us-gaap:GrossProfit |
| Research and development | 3 months2023-12-30 to 2024-03-29 | $13.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-12-30 to 2024-03-29 | $63.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-12-30 to 2024-03-29 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-12-30 to 2024-03-29 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-30 to 2024-03-29 | −$3.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-12-30 to 2024-03-29 | −$0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-30 to 2024-03-29 | −$0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-30 to 2024-03-29 | 48,907,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-12-30 to 2024-03-29 | $21.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-12-30 to 2024-03-29 | $5.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-29 | $224.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-29 | $365.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-29 | $492.5m | us-gaap:Assets |
| Current liabilities | At period end2024-03-29 | $62.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-29 | $99.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-29 | $392.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-054488. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.